Background: Vitiligo is a prevalent autoimmune skin disorder characterized by progressive depigmented patches of the skin and/or mucosa. Lately, extensive research has been investigating molecular pathogenesis underlying vitiligo, epidermal-immune cell crosstalk, structural aberrations in cellular skin components and immune cell metabolism derangements. Glucose transporter-1 (GLUT-1) has recently proved to be increased in proinflammatory conditions and autoimmune diseases. GLUT-1 expression is upregulated in rheumatoid arthritis, systemic lupus erythematosus, psoriasis and chronic spongiotic dermatitis.
Objective: To investigate GLUT-1 expression in vitiligo.
Subjects And Methods: The study included 30 vitiligo patients "vitiligo vulgaris" and 30 healthy individuals. Biopsies of the patients' lesional vitiligo skin and the control group's normal skin were obtained. They were all tested for GLUT-1 mRNA expression using real-time polymerase chain reaction (RT-PCR) and GLUT-1 antibody expression using immunohistochemistry (IHC). Hematoxylin and eosin (H&E) staining for the specimens was additionally done for histopathological assessment.
Results: GLUT-1 expression was upregulated in lesional skin of vitiligo patients compared to normal control skin (P-value < 0.001). Also, lesional specimens from stable disease showed more GLUT-1 expression than active disease but without a significant difference (P-value = 0.283). There was no significant correlation between the proposed vitiligo histological scoring system and vitiligo signs of the disease activity score.
Conclusion: GLUT-1 could play a crucial role in vitiligo disease onset, persistence and progression, through keratinocyte-melanocyte-fibroblast-immune cell crosstalk, being the initially deranged metabolic pathway for all these cells giving an insight into vitiligo metabolomics.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.gene.2025.149383 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Glucose transporter-1 (GLUT-1) upregulation in vitiligo: A possible link to skin depigmentation.
Gene
March 2025
Department of Dermatology, Venereology and Andrology Faculty of Medicine, Suez Canal University, Ismailia 41522, Egypt. Electronic address:
Background: Vitiligo is a prevalent autoimmune skin disorder characterized by progressive depigmented patches of the skin and/or mucosa. Lately, extensive research has been investigating molecular pathogenesis underlying vitiligo, epidermal-immune cell crosstalk, structural aberrations in cellular skin components and immune cell metabolism derangements. Glucose transporter-1 (GLUT-1) has recently proved to be increased in proinflammatory conditions and autoimmune diseases.
View Article and Find Full Text PDFFemale sex hormones and the oral contraceptive pill modulate asthma severity through GLUT-1.
Mucosal Immunol
February 2025
The University of Newcastle and Immune Health Program, Hunter Medical Research Institute, Newcastle, New South Wales, Australia. Electronic address:
Females are disproportionately affected by asthma. An increased understanding of how female sex hormones influence key pathophysiological processes that underpin asthma may identify new, more effective asthma therapies, particularly for females with severe, poorly controlled asthma. We assessed the effects of oral ethinylestradiol/levonorgestrel (representing OCP use) and depot-medroxyprogesterone acetate (DMPA) and estradiol injections on key features of experimental asthma, and determined their effects on glucose transporter-1 (GLUT-1).
View Article and Find Full Text PDFOntogeny of Fetal Cardiometabolic Pathways: The Potential Role of Cortisol and Thyroid Hormones in Driving the Transition from Preterm to Near-Term Heart Development in Sheep.
J Cardiovasc Dev Dis
January 2025
Early Origins of Adult Health Research Group, Health and Biomedical Innovation, UniSA: Clinical and Health Sciences, University of South Australia, Adelaide, SA 5001, Australia.
Understanding hormonal and molecular changes during the transition from preterm to near-term gestation is essential for investigating how pregnancy complications impact fetal heart development and contribute to long-term cardiovascular risks for offspring. This study examines these cardiac changes in fetal sheep, focusing on the changes between 116 days (preterm) and 140 days (near term) of gestation (dG, term = 150) using Western blotting, LC-MS/MS, and histological techniques. We observed a strong correlation between cortisol and T (Triiodothyronine) in heart tissue in near-term fetuses, highlighting the role of glucocorticoid signalling in fetal heart maturation.
View Article and Find Full Text PDFGlut-1 exerts anti-tumor activity in glioma by regulating AKT / mTOR signaling pathway.
Technol Health Care
January 2025
Department of Neurosurgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
Objective: Glioma is a common tumor in neurosurgery. Glut-1 is the main carrier of glucose uptake by cells and can provide energy through the glycolytic pathway. However, the role and related mechanisms of Glut-1 in glioma have not yet been elucidated.
View Article and Find Full Text PDFGlucose transporter 1 (GLUT1) is a sensitive immunohistochemical marker for perineural cells and certain mesenchymal neoplasms, including chordoma, desmoplastic small round cell tumor, desmoid-type fibromatosis, epithelioid sarcoma, gastrointestinal stromal tumor, myoepithelioma, schwannoma, and undifferentiated pleomorphic sarcoma. In this study, we focus on the morphological and immunohistochemical challenges in differentiating between ganglion cysts and perineuriomas. To our knowledge, no previous studies have explored the potential morphological and immunohistochemical similarities between these two lesions.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!